|
Havlir, D; Cheeseman, S H; McLaughlin, M et al. (1995) High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis 171:537-45
|
|
Cheeseman, S H; Havlir, D; McLaughlin, M M et al. (1995) Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 8:141-51
|
|
Lai, K K (1994) Attitudes toward childbearing and changes in sexual and contraceptive practices among HIV-infected women. Cleve Clin J Med 61:132-6;quiz 161
|
|
Lai, K K (1992) Consent to treatment with zidovudine among HIV-infected patients. Cleve Clin J Med 59:45-7
|
|
Koup, R A; Pikora, C A; Mazzara, G et al. (1991) Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection. Viral Immunol 4:215-23
|
|
Alimenti, A; Luzuriaga, K; Stechenberg, B et al. (1991) Quantitation of human immunodeficiency virus in vertically infected infants and children. J Pediatr 119:225-9
|
|
Koup, R A; Robinson, J E; Nguyen, Q V et al. (1991) Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1. AIDS 5:1309-14
|
|
Luzuriaga, K; Koup, R A; Pikora, C A et al. (1991) Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J Pediatr 119:230-6
|
|
Koup, R A; Merluzzi, V J; Hargrave, K D et al. (1991) Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J Infect Dis 163:966-70
|
|
Koup, R A; Pikora, C A; Luzuriaga, K et al. (1991) Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 174:1593-600
|
Showing the most recent 10 out of 11 publications
